We are live on
!
Find out more
N
Natixis Portfolio holdings
AUM
$28B
1-Year Est. Return
26.79%
Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.
This Fund
S&P 500
This Quarter
Est. Return
-2.18%
1 Year Est. Return
+26.79%
3 Year Est. Return
+97.72%
5 Year Est. Return
+108.83%
10 Year Est. Return
+452.99%
AUM
$13.1B
AUM Growth
+$754M
(+6.1%)
Cap. Flow
+$1.16B
Cap. Flow
% of AUM
8.89%
Top 10 Holdings %
Top 10 Hldgs %
38.02%
Holding
1,188
New
182
Increased
340
Reduced
340
Closed
221
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$379M |
| 2 |
NVIDIA
NVDA
|
+$323M |
| 3 |
Amazon
AMZN
|
+$133M |
| 4 |
UnitedHealth
UNH
|
+$97.5M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$86.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$89.2M |
| 2 |
ExxonMobil
XOM
|
+$83.6M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$83.1M |
| 4 |
CVS Health
CVS
|
+$82.2M |
| 5 |
Eli Lilly
LLY
|
+$66.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.23% |
| 2 | Healthcare | 11.42% |
| 3 | Energy | 7.9% |
| 4 | Consumer Discretionary | 6.67% |
| 5 | Financials | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Valero Energy
VLO
$89.8B
| $34.2K | ﹤0.01% |
241
-170,972
| -100% | -$22.4M |
|
|
SCWX
827
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $32.4K | ﹤0.01% |
5,222
| – | – |
|
828
The Ensign Group
ENSG
$10.1B
| $31.8K | ﹤0.01% |
342
-86
| -20% | -$8.14K |
|
|
MOMO
829
Hello Group
MOMO
$869M
| $31.4K | ﹤0.01% |
4,501
+4,500
| +450,000% | +$41.4K |
|
830
Kinross Gold
KGC
$28.5B
| $30.8K | ﹤0.01% |
6,759
-1,740,809
| -100% | -$8.53M |
|
831
Novavax
NVAX
$1.23B
| $29.9K | ﹤0.01% |
+4,125
| New | +$33K |
|
832
Magna International
MGA
$17.9B
| $29.6K | ﹤0.01% |
+551
| New | +$32.1K |
|
833
Invesco China Technology ETF
CQQQ
$2.95B
| $29.5K | ﹤0.01% |
816
+12
| +1% | +$475 |
|
834
Snap
SNAP
$7.32B
| $29.4K | ﹤0.01% |
+3,302
| New | +$34.5K |
|
835
Prestige Consumer Healthcare
PBH
$2.35B
| $28.8K | ﹤0.01% |
503
-235
| -32% | -$14.2K |
|
836
Alliant Energy
LNT
$19.4B
| $28.4K | ﹤0.01% |
586
+23
| +4% | +$1.19K |
|
837
IonQ
IONQ
$12.3B
| $27.1K | ﹤0.01% |
+1,783
| New | +$28K |
|
838
Fox Class A
FOXA
$23.2B
| $26.9K | ﹤0.01% |
861
-392,823
| -100% | -$12.9M |
|
839
Chewy
CHWY
$8.54B
| $26.8K | ﹤0.01% |
1,467
+258
| +21% | +$7.38K |
|
|
RNAM
840
DELISTED
Avidity Biosciences
RNAM
| $26.7K | ﹤0.01% |
4,185
-14
| -0.3% | -$121 |
|
841
Merit Medical Systems
MMSI
$4.43B
| $26.1K | ﹤0.01% |
378
-158
| -29% | -$11.4K |
|
|
KYNB
842
Kyntra Bio
KYNB
$28.5M
| $25.9K | ﹤0.01% |
1,200
-1,996
| -62% | -$78.4K |
|
843
ARK Web x.0 ETF
ARKW
$1.64B
| $25.9K | ﹤0.01% |
477
-398
| -45% | -$23.6K |
|
844
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.42B
| $25.7K | ﹤0.01% |
+174
| New | +$24.9K |
|
845
Meritage Homes
MTH
$4.87B
| $25.6K | ﹤0.01% |
+418
| New | +$28.7K |
|
846
Knife River
KNF
$4.43B
| $25.4K | ﹤0.01% |
521
-3
| -0.6% | -$142 |
|
847
Equifax
EFX
$20.3B
| $24.7K | ﹤0.01% |
+135
| New | +$27.6K |
|
|
XOMA
848
DELISTED
Xoma
XOMA
| $24.3K | ﹤0.01% |
1,726
| – | – |
|
849
ScottsMiracle-Gro
SMG
$4.03B
| $24.3K | ﹤0.01% |
+470
| New | +$27.2K |
|
850
VanEck Gold Miners ETF
GDX
$23B
| $23.8K | ﹤0.01% |
884
-225
| -20% | -$6.63K |
|
Similar funds
TWC
FDCDDQ
PCH
NA
Natixis's Q3 2023 Portfolio in Review
As of Q3 2023, Natixis held 1,188 positions worth $13.1B, up 6.1% from $12.3B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Natixis deployed $1.16B of net new capital in Q3 2023, opening 182 new positions and adding to 340 existing holdings. Its largest new stake was Oneok: 965,015 shares worth $61.2M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 21% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $89.2M trimmed.
- Natixis's largest Q3 2023 buy was Oneok: 965,015 shares worth $61.2M.
- Natixis added most to Apple in Q3 2023, an estimated $379M increase.
- Natixis's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $89.2M.
- Natixis fully exited Bristol-Myers Squibb in Q3 2023, selling an estimated $83.1M.
- Natixis's ten largest holdings make up 38% of its $13.1B portfolio in Q3 2023.
- Natixis opened 182 new positions and closed 221 in Q3 2023.
- Natixis's portfolio value rose 6.1% quarter-over-quarter to $13.1B.
Based on Natixis's 13F filing for Q3 2023, filed 14 Nov 2023.